Takeda Pharmaceutical Company (TAK) has released an update.
Takeda Pharmaceutical Company Limited has announced corrections to the Notice of Convocation for its 148th Ordinary General Meeting of Shareholders. The amendments pertain to the number of Company ADS (American Depositary Shares) allocated to executives Christophe Weber and Dr. Andrew Plump, with minor adjustments to the previously stated figures.
For further insights into TAK stock, check out TipRanks’ Stock Analysis page.
